Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does IDURSULFASE Cause Product dose omission issue? 450 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 450 reports of Product dose omission issue have been filed in association with IDURSULFASE (ELAPRASE). This represents 14.1% of all adverse event reports for IDURSULFASE.

450
Reports of Product dose omission issue with IDURSULFASE
14.1%
of all IDURSULFASE reports
66
Deaths
247
Hospitalizations

How Dangerous Is Product dose omission issue From IDURSULFASE?

Of the 450 reports, 66 (14.7%) resulted in death, 247 (54.9%) required hospitalization, and 18 (4.0%) were considered life-threatening.

Is Product dose omission issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for IDURSULFASE. However, 450 reports have been filed with the FAERS database.

What Other Side Effects Does IDURSULFASE Cause?

Pyrexia (524) Inappropriate schedule of product administration (371) Cough (263) Infusion related reaction (241) Pneumonia (232) Death (222) Dyspnoea (202) Influenza (200) Covid-19 (197) Seizure (195)

What Other Drugs Cause Product dose omission issue?

DUPILUMAB (18,189) USTEKINUMAB (9,405) GUSELKUMAB (9,267) LENALIDOMIDE (8,145) MEPOLIZUMAB (5,873) TOFACITINIB (5,646) VOXELOTOR (5,122) BELIMUMAB (4,671) SECUKINUMAB (4,572) APREMILAST (4,460)

Which IDURSULFASE Alternatives Have Lower Product dose omission issue Risk?

IDURSULFASE vs IFOSFAMIDE IDURSULFASE vs IGURATIMOD IDURSULFASE vs ILOPERIDONE IDURSULFASE vs ILOPROST IDURSULFASE vs IMATINIB

Related Pages

IDURSULFASE Full Profile All Product dose omission issue Reports All Drugs Causing Product dose omission issue IDURSULFASE Demographics